{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T02:05:32Z","timestamp":1790301932649,"version":"4.1.0"},"reference-count":20,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,12]],"date-time":"2021-06-12T00:00:00Z","timestamp":1623456000000},"content-version":"am","delay-in-days":346,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Joint Bone Spine"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.jbspin.2019.11.008","type":"journal-article","created":{"date-parts":[[2019,12,4]],"date-time":"2019-12-04T11:47:15Z","timestamp":1575460035000},"page":"285-288","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Stem cells: Hope for systemic sclerosis patients?"],"prefix":"10.1016","volume":"87","author":[{"given":"Yannick","family":"Allanore","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbspin.2019.11.008_bib0105","doi-asserted-by":"crossref","first-page":"15002","DOI":"10.1038\/nrdp.2015.2","article-title":"Systemic sclerosis","volume":"1","author":"Allanore","year":"2015","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.jbspin.2019.11.008_bib0110","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1136\/annrheumdis-2017-211448","article-title":"Mapping and predicting mortality from systemic sclerosis","volume":"76","author":"Elhai","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2019.11.008_bib0115","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1038\/s41409-019-0430-7","volume":"54","author":"Jessop","year":"2019","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jbspin.2019.11.008_bib0120","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1001\/jama.2018.18743","article-title":"Effect of nonmyeloablative hematopoietic stem cell transplantation vs. continued disease-modifying therapy on disease progression in patients with relapsing-remitting multiple sclerosis: a randomized clinical trial","volume":"321","author":"Burt","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.jbspin.2019.11.008_bib0125","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/S0140-6736(11)60982-3","article-title":"Autologous non-myeloablative haemopoietic stem-cell transplantation compared with pulse cyclophosphamide once per month for systemic sclerosis (ASSIST): an open-label, randomised phase 2 trial","volume":"378","author":"Burt","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.jbspin.2019.11.008_bib0130","doi-asserted-by":"crossref","first-page":"2490","DOI":"10.1001\/jama.2014.6368","article-title":"Autologous hematopoietic stem cell transplantation vs intravenous pulse cyclophosphamide in diffuse cutaneous systemic sclerosis: a randomized clinical trial","volume":"311","author":"van Laar","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.jbspin.2019.11.008_bib0135","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1056\/NEJMoa1703327","volume":"378","author":"Sullivan","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jbspin.2019.11.008_bib0140","first-page":"CD009768","article-title":"Mesenchymal stromal cells as treatment or prophylaxis for acute or chronic graft-versus-host disease in haematopoietic stem cell transplant (HSCT) recipients with a haematological condition","volume":"1","author":"Fisher","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jbspin.2019.11.008_bib0145","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.3389\/fimmu.2018.02013","article-title":"Mesenchymal stromal cells based therapy in systemic sclerosis: rationale and challenges","volume":"9","author":"Peltzer","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.jbspin.2019.11.008_bib0150","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.3389\/fimmu.2018.02571","article-title":"Fibrosis development in HOCl-induced systemic sclerosis: a multistage process hampered by mesenchymal stem cells","volume":"9","author":"Maria","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.jbspin.2019.11.008_bib0155","doi-asserted-by":"crossref","first-page":"650","DOI":"10.7326\/0003-4819-153-10-201011160-00007","article-title":"Autologous mesenchymal stem cells foster revascularization of ischemic limbs in systemic sclerosis: a case report","volume":"153","author":"Guiducci","year":"2010","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jbspin.2019.11.008_bib0160","doi-asserted-by":"crossref","first-page":"2540","DOI":"10.1002\/art.30431","article-title":"Treatment of severe progressive systemic sclerosis with transplantation of mesenchymal stromal cells from allogeneic related donors: report of five cases","volume":"63","author":"Keyszer","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2019.11.008_bib0165","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1093\/rheumatology\/ken407","article-title":"Autologous progenitor cell implantation as a novel therapeutic intervention for ischaemic digits in systemic sclerosis","volume":"48","author":"Nevskaya","year":"2009","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jbspin.2019.11.008_bib0170","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1093\/rheumatology\/ket432","article-title":"Therapeutic vascular angiogenesis for intractable macroangiopathy-related digital ulcer in patients with systemic sclerosis: a pilot study","volume":"53","author":"Takagi","year":"2014","journal-title":"Rheumatology (UK)"},{"key":"10.1016\/j.jbspin.2019.11.008_bib0175","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.3727\/096368915X688218","article-title":"Regional implantation of autologous adipose tissue-derived cells induces a prompt healing of long-lasting indolent digital ulcers in patients with systemic sclerosis","volume":"24","author":"Del Papa","year":"2015","journal-title":"Cell Transplant"},{"key":"10.1016\/j.jbspin.2019.11.008_bib0180","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1136\/annrheumdis-2014-205681","article-title":"Safety, tolerability and potential efficacy of injection of autologous adipose-derived stromal vascular fraction in the fingers of patients with systemic sclerosis: an open-label phase I trial","volume":"74","author":"Granel","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2019.11.008_bib0185","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s13075-018-1792-8","article-title":"Regional grafting of autologous adipose tissue is effective in inducing prompt healing of indolent digital ulcers in patients with systemic sclerosis: results of a monocentric randomized controlled study","volume":"21","author":"Del Papa","year":"2019","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.jbspin.2019.11.008_bib0190","doi-asserted-by":"crossref","first-page":"290ra87","DOI":"10.1126\/scitranslmed.aaa9301","article-title":"Citrullinated peptide dendritic cell immunotherapy in HLA risk genotype-positive rheumatoid arthritis patients","volume":"7","author":"Benham","year":"2015","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jbspin.2019.11.008_bib0195","doi-asserted-by":"crossref","first-page":"8463","DOI":"10.1073\/pnas.1820039116","article-title":"Immune tolerance in multiple sclerosis and neuromyelitis optica with peptide-loaded tolerogenic dendritic cells in a phase 1b trial","volume":"116","author":"Zubizarreta","year":"2019","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jbspin.2019.11.008_bib0200","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.3389\/fimmu.2018.02356","article-title":"Regulatory T cells in systemic sclerosis","volume":"9","author":"Frantz","year":"2018","journal-title":"Front Immunol"}],"container-title":["Joint Bone Spine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297319X19301745?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297319X19301745?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T16:26:10Z","timestamp":1761150370000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1297319X19301745"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":20,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["S1297319X19301745"],"URL":"https:\/\/doi.org\/10.1016\/j.jbspin.2019.11.008","relation":{},"ISSN":["1297-319X"],"issn-type":[{"value":"1297-319X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Stem cells: Hope for systemic sclerosis patients?","name":"articletitle","label":"Article Title"},{"value":"Joint Bone Spine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jbspin.2019.11.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier Masson SAS on behalf of Soci\u00e9t\u00e9 fran\u00e7aise de rhumatologie.","name":"copyright","label":"Copyright"}]}}